A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Moderna, Inc. stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 73,236 shares of MRNA stock, worth $4.82 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
73,236
Previous 72,822 0.57%
Holding current value
$4.82 Million
Previous $7.76 Million 12.08%
% of portfolio
0.06%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$101.21 - $166.61 $41,900 - $68,976
414 Added 0.57%
73,236 $8.7 Million
Q1 2024

May 08, 2024

BUY
$85.37 - $115.44 $15,366 - $20,779
180 Added 0.25%
72,822 $7.76 Million
Q4 2023

Feb 09, 2024

BUY
$69.51 - $104.43 $421,578 - $633,367
6,065 Added 9.11%
72,642 $7.22 Million
Q3 2023

Nov 09, 2023

BUY
$96.41 - $126.61 $906,350 - $1.19 Million
9,401 Added 16.44%
66,577 $6.88 Million
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $138,171 - $187,177
1,166 Added 2.08%
57,176 $6.95 Million
Q1 2023

May 09, 2023

BUY
$135.66 - $197.02 $21,976 - $31,917
162 Added 0.29%
56,010 $8.6 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $785,806 - $1.39 Million
6,638 Added 13.49%
55,848 $10 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $138,732 - $228,161
-1,175 Reduced 2.33%
49,210 $5.82 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $373,293 - $562,792
3,187 Added 6.75%
50,385 $7.2 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $369,642 - $687,051
2,923 Added 6.6%
47,198 $8.13 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $60,293 - $98,392
267 Added 0.61%
44,275 $11.2 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $9.77 Million - $21.3 Million
44,008 New
44,008 $16.9 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.